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Background
HIV is a retrovirus having ss RNA as the genetic mate-
rial, which gets converted into ds DNA in the presence
of reverse transcriptase (RT) enzyme. RT has been
found the most attractive target for development of anti
HIV-1 agents. Its inhibition is considered as one of the
most practical approaches to prevent HIV infection.
Methods
NNRTIs are non-competitive inhibitors and bind at
allosteric site. Designing of non nucleoside analogs of
pyrimidine as NNRTIs has been done on the basis of
Lipinski’s Rule of Five & using the software DS 3.0. The
molecules have been docked with HIV-RT using DS 3.0
in order to generate computational data and assess their
suitability.
Results
Docking experiments have shown good interaction of
non nucleoside analogs of pyrimidine as NNRTIs. Ana-
lysis of the docking results revealed that these molecules
adopted butterfly conformations while interacting at
NNIBP of HIV-1 RT & formed hydrogen bonds with
amino acids, Lys101, Lys103, Tyr181, Tyr318 and
π-stacking interactions with Tyr181, Tyr188, Phe227
and Trp229.
Conclusion
The molecular modeling revealed the interaction level of
these molecules comparable to that of nevirapine.
Hence, we predict these molecules as potential NNRTIs
against HIV-1 RT.
Published: 27 May 2014
doi:10.1186/1471-2334-14-S3-E3
Cite this article as: Srivastava et al.: Computational studies on non-
nucleoside analogs of pyrimidine as NNRTIs against HIV-1. BMC
Infectious Diseases 2014 14(Suppl 3):E3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: rksinghsrk@gmail.com
Nucleic Acids and Antiviral Research Laboratory, Department of Chemistry,
University of Allahabad, Allahabad (UP) - 211002, India
Srivastava et al. BMC Infectious Diseases 2014, 14(Suppl 3):E3
http://www.biomedcentral.com/1471-2334/14/S3/E3
© 2014 Srivastava et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
